224 related articles for article (PubMed ID: 10510206)
1. Cell biology of Paget's disease.
Reddy SV; Menaa C; Singer FR; Demulder A; Roodman GD
J Bone Miner Res; 1999 Oct; 14 Suppl 2():3-8. PubMed ID: 10510206
[TBL] [Abstract][Full Text] [Related]
2. 1,25-Dihydroxyvitamin D3 hypersensitivity of osteoclast precursors from patients with Paget's disease.
Menaa C; Barsony J; Reddy SV; Cornish J; Cundy T; Roodman GD
J Bone Miner Res; 2000 Feb; 15(2):228-36. PubMed ID: 10703924
[TBL] [Abstract][Full Text] [Related]
3. Osteoclast differentiation from circulating mononuclear precursors in Paget's disease is hypersensitive to 1,25-dihydroxyvitamin D(3) and RANKL.
Neale SD; Smith R; Wass JA; Athanasou NA
Bone; 2000 Sep; 27(3):409-16. PubMed ID: 10962353
[TBL] [Abstract][Full Text] [Related]
4. Role of TAFII-17, a VDR binding protein, in the increased osteoclast formation in Paget's Disease.
Kurihara N; Reddy SV; Araki N; Ishizuka S; Ozono K; Cornish J; Cundy T; Singer FR; Roodman GD
J Bone Miner Res; 2004 Jul; 19(7):1154-64. PubMed ID: 15176999
[TBL] [Abstract][Full Text] [Related]
5. Atypical multinucleated cells form in long-term marrow cultures from patients with Paget's disease.
Kukita A; Chenu C; McManus LM; Mundy GR; Roodman GD
J Clin Invest; 1990 Apr; 85(4):1280-6. PubMed ID: 2318982
[TBL] [Abstract][Full Text] [Related]
6. Abnormalities in osteoclast precursors and marrow accessory cells in Paget's disease.
Demulder A; Takahashi S; Singer FR; Hosking DJ; Roodman GD
Endocrinology; 1993 Nov; 133(5):1978-82. PubMed ID: 7691583
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D antagonist, TEI-9647, inhibits osteoclast formation induced by 1alpha,25-dihydroxyvitamin D3 from pagetic bone marrow cells.
Ishizuka S; Kurihara N; Miura D; Takenouchi K; Cornish J; Cundy T; Reddy SV; Roodman GD
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):331-4. PubMed ID: 15225795
[TBL] [Abstract][Full Text] [Related]
8. Etiology of Paget's disease and osteoclast abnormalities.
Reddy SV
J Cell Biochem; 2004 Nov; 93(4):688-96. PubMed ID: 15389972
[TBL] [Abstract][Full Text] [Related]
9. (23S)-25-Dehydro-1{alpha}-hydroxyvitamin D3-26,23-lactone, a vitamin D receptor antagonist that inhibits osteoclast formation and bone resorption in bone marrow cultures from patients with Paget's disease.
Ishizuka S; Kurihara N; Reddy SV; Cornish J; Cundy T; Roodman GD
Endocrinology; 2005 Apr; 146(4):2023-30. PubMed ID: 15618361
[TBL] [Abstract][Full Text] [Related]
10. Osteoclast function in Paget's disease and multiple myeloma.
Roodman GD
Bone; 1995 Aug; 17(2 Suppl):57S-61S. PubMed ID: 8579899
[TBL] [Abstract][Full Text] [Related]
11. Interleukin 6. A potential autocrine/paracrine factor in Paget's disease of bone.
Roodman GD; Kurihara N; Ohsaki Y; Kukita A; Hosking D; Demulder A; Smith JF; Singer FR
J Clin Invest; 1992 Jan; 89(1):46-52. PubMed ID: 1729280
[TBL] [Abstract][Full Text] [Related]
12. Enhanced RANK ligand expression and responsivity of bone marrow cells in Paget's disease of bone.
Menaa C; Reddy SV; Kurihara N; Maeda H; Anderson D; Cundy T; Cornish J; Singer FR; Bruder JM; Roodman GD
J Clin Invest; 2000 Jun; 105(12):1833-8. PubMed ID: 10862799
[TBL] [Abstract][Full Text] [Related]
13. Paget's disease-a VDR coactivator disease?
Kurihara N; Ishizuka S; Demulder A; Menaa C; Roodman GD
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):321-5. PubMed ID: 15225793
[TBL] [Abstract][Full Text] [Related]
14. Paget's disease of bone: a disease of the osteoclast.
Reddy SV; Kurihara N; Menaa C; Roodman GD
Rev Endocr Metab Disord; 2001 Apr; 2(2):195-201. PubMed ID: 11705325
[TBL] [Abstract][Full Text] [Related]
15. Multinucleated cells formed in vitro from Paget's bone marrow express viral antigens.
Mills BG; Frausto A; Singer FR; Ohsaki Y; Demulder A; Roodman GD
Bone; 1994; 15(4):443-8. PubMed ID: 7917585
[TBL] [Abstract][Full Text] [Related]
16. The influence of serum cytokines and growth factors on osteoclast formation in Paget's disease.
Neale SD; Schulze E; Smith R; Athanasou NA
QJM; 2002 Apr; 95(4):233-40. PubMed ID: 11937650
[TBL] [Abstract][Full Text] [Related]
17. Paget's disease and osteoclast biology.
Roodman GD
Bone; 1996 Sep; 19(3):209-12. PubMed ID: 8873960
[TBL] [Abstract][Full Text] [Related]
18. Osteoclasts formed by measles virus-infected osteoclast precursors from hCD46 transgenic mice express characteristics of pagetic osteoclasts.
Reddy SV; Kurihara N; Menaa C; Landucci G; Forthal D; Koop BA; Windle JJ; Roodman GD
Endocrinology; 2001 Jul; 142(7):2898-905. PubMed ID: 11416009
[TBL] [Abstract][Full Text] [Related]
19. Increased IL-6 expression in osteoclasts is necessary but not sufficient for the development of Paget's disease of bone.
Teramachi J; Zhou H; Subler MA; Kitagawa Y; Galson DL; Dempster DW; Windle JJ; Kurihara N; Roodman GD
J Bone Miner Res; 2014 Jun; 29(6):1456-65. PubMed ID: 24339057
[TBL] [Abstract][Full Text] [Related]
20. Role of ATF7-TAF12 interactions in the vitamin D response hypersensitivity of osteoclast precursors in Paget's disease.
Teramachi J; Hiruma Y; Ishizuka S; Ishizuka H; Brown JP; Michou L; Cao H; Galson DL; Subler MA; Zhou H; Dempster DW; Windle JJ; Roodman GD; Kurihara N
J Bone Miner Res; 2013 Jun; 28(6):1489-500. PubMed ID: 23426901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
